United States

Celcuity Inc. is a biotech company focused on developing targeted therapies for cancer patients. Their CELsignia diagnostic platform uses a patient's tumor cells to identify the specific abnormal cellular process driving their cancer and determine the appropriate treatment. They are developing a drug candidate called Gedatolisib for hormone receptor positive, HER2-negative, and advanced breast cancer. They are also working on a test to measure signaling activity in breast and ovarian tumor cells. Celcuity has a license agreement with Pfizer for Gedatolisib and was founded in 2011 in Minneapolis.

Celcuity

Director, Medical Science Liaison, New England

Director, Medical Science Liaison, North Central US

Vice President, Commercial Operations

Senior Manager, Regulatory Affairs, CMC

Senior Manager, Statistical Programming

Senior Director, Scientific Strategy and Communications

Director, Biostatistics

Associate Director, Medical Writing

Director, Medical Science Liaison, Carolinas

Director, Medical Science Liaison, Northwest

Google

Produktový manažer

Datový analytik

Celcuity

Celcuity Otevřené pozice

Jste připraveni posunout svoji kariéru na další úroveň? Podívejte se na tyto otevřené pozice ve společnosti Celcuity.